Lillys

CVS Caremark will cover Lilly’s weight loss drug Zepbound once again

by

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. CVS Caremark is one of the country’s largest pharmacy benefit managers, … Read more

People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says

by

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The results are on par … Read more